Orbimed Advisors as of June 30, 2015
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 130 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 4.6 | $549M | 8.3M | 66.54 | |
| Biogen Idec (BIIB) | 4.3 | $517M | 1.3M | 403.94 | |
| Abbvie (ABBV) | 3.9 | $468M | 7.0M | 67.19 | |
| Allergan SHS | 3.9 | $466M | 1.5M | 303.46 | |
| Hca Holdings (HCA) | 3.8 | $455M | 5.0M | 90.72 | |
| Celgene Corporation | 3.7 | $443M | 3.8M | 115.73 | |
| Amgen (AMGN) | 3.7 | $442M | 2.9M | 153.52 | |
| Boston Scientific Corporation (BSX) | 3.2 | $384M | 22M | 17.70 | |
| Alexion Pharmaceuticals | 3.1 | $370M | 2.0M | 180.77 | |
| Gilead Sciences (GILD) | 2.8 | $339M | 2.9M | 117.08 | |
| Impax Laboratories | 2.6 | $316M | 6.9M | 45.92 | |
| Shire Sponsored Adr | 2.6 | $315M | 1.3M | 241.49 | |
| Intercept Pharmaceuticals In | 2.3 | $270M | 1.1M | 241.38 | |
| Illumina (ILMN) | 2.1 | $251M | 1.2M | 218.36 | |
| Molina Healthcare (MOH) | 2.0 | $245M | 3.5M | 70.30 | |
| Relypsa | 2.0 | $245M | 7.4M | 33.09 | |
| Neurocrine Biosciences (NBIX) | 2.0 | $243M | 5.1M | 47.76 | |
| Incyte Corporation (INCY) | 2.0 | $241M | 2.3M | 104.21 | |
| Health Net | 2.0 | $237M | 3.7M | 64.12 | |
| Regeneron Pharmaceuticals (REGN) | 2.0 | $236M | 462k | 510.13 | |
| Cooper Cos Com New | 1.9 | $232M | 1.3M | 177.97 | |
| Thermo Fisher Scientific (TMO) | 1.5 | $182M | 1.4M | 129.76 | |
| McKesson Corporation (MCK) | 1.3 | $161M | 718k | 224.81 | |
| Medivation | 1.3 | $161M | 1.4M | 114.20 | |
| Bluebird Bio (BLUE) | 1.3 | $161M | 958k | 168.37 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 1.3 | $150M | 12M | 12.06 | |
| Intuitive Surgical Com New (ISRG) | 1.2 | $146M | 301k | 484.50 | |
| Agilent Technologies Inc C ommon (A) | 1.2 | $142M | 3.7M | 38.58 | |
| Tesaro | 1.0 | $122M | 2.1M | 58.79 | |
| Tornier N V SHS | 1.0 | $120M | 4.8M | 24.99 | |
| Receptos | 1.0 | $119M | 628k | 190.05 | |
| Express Scripts Holding | 1.0 | $119M | 1.3M | 88.94 | |
| Puma Biotechnology (PBYI) | 0.9 | $110M | 941k | 116.75 | |
| Allergan Pfd Conv Ser A | 0.9 | $109M | 104k | 1045.68 | |
| Pfizer (PFE) | 0.9 | $102M | 3.1M | 33.53 | |
| Magellan Health Com New | 0.8 | $102M | 1.5M | 70.07 | |
| Community Health Systems (CYH) | 0.8 | $96M | 1.5M | 62.97 | |
| Insys Therapeutics Com New | 0.8 | $94M | 2.6M | 35.92 | |
| Mallinckrodt Pub SHS | 0.8 | $94M | 795k | 117.72 | |
| Clovis Oncology | 0.7 | $88M | 1.0M | 87.88 | |
| Wright Medical | 0.7 | $88M | 3.3M | 26.26 | |
| Ophthotech | 0.7 | $87M | 1.7M | 52.06 | |
| Glaukos (GKOS) | 0.7 | $84M | 2.9M | 28.98 | |
| Affymetrix | 0.7 | $82M | 7.5M | 10.92 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.7 | $81M | 4.4M | 18.33 | |
| Sientra | 0.7 | $80M | 3.2M | 25.23 | |
| Affimed Therapeutics B V | 0.7 | $78M | 5.8M | 13.47 | |
| Array BioPharma | 0.6 | $76M | 11M | 7.21 | |
| NuVasive | 0.6 | $71M | 1.5M | 47.38 | |
| Johnson & Johnson (JNJ) | 0.5 | $60M | 617k | 97.46 | |
| D Fluidigm Corp Del (LAB) | 0.5 | $59M | 2.4M | 24.20 | |
| EXACT Sciences Corporation (EXAS) | 0.4 | $53M | 1.8M | 29.74 | |
| Otonomy | 0.4 | $52M | 2.3M | 22.99 | |
| Infinity Pharmaceuticals (INFIQ) | 0.4 | $48M | 4.4M | 10.95 | |
| Medtronic SHS (MDT) | 0.4 | $48M | 646k | 74.10 | |
| Chimerix (CMRX) | 0.4 | $47M | 1.0M | 46.20 | |
| Cerus Corporation (CERS) | 0.4 | $43M | 8.3M | 5.19 | |
| Insmed Com Par $.01 (INSM) | 0.3 | $42M | 1.7M | 24.42 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 0.3 | $41M | 200k | 205.85 | |
| Gw Pharmaceuticals Ads | 0.3 | $40M | 325k | 122.84 | |
| Loxo Oncology | 0.3 | $39M | 2.2M | 18.03 | |
| Portola Pharmaceuticals | 0.3 | $39M | 851k | 45.55 | |
| Valeant Pharmaceuticals Int | 0.3 | $37M | 165k | 222.15 | |
| Forward Pharma A/s Sponsored Adr | 0.3 | $37M | 961k | 38.05 | |
| XenoPort | 0.3 | $35M | 5.8M | 6.13 | |
| Horizon Pharma SHS | 0.3 | $33M | 951k | 34.74 | |
| Incyte Corp Note 4.750%10/0 (Principal) | 0.3 | $32M | 2.7M | 11.83 | |
| Aduro Biotech | 0.3 | $32M | 1.1M | 30.33 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.3 | $31M | 1.8M | 16.67 | |
| Dyax | 0.2 | $30M | 1.1M | 26.50 | |
| UnitedHealth (UNH) | 0.2 | $29M | 238k | 122.00 | |
| Synergy Pharmaceuticals Del Com New | 0.2 | $28M | 3.4M | 8.30 | |
| Assembly Biosciences | 0.2 | $27M | 1.4M | 19.26 | |
| Galapagos Nv Spon Adr (GLPG) | 0.2 | $26M | 513k | 51.50 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $26M | 188k | 136.78 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.2 | $26M | 1.4M | 17.68 | |
| Merck & Co (MRK) | 0.2 | $24M | 415k | 56.93 | |
| Cynapsus Therapeutics Com Par No Par | 0.2 | $23M | 1.1M | 20.41 | |
| Zimmer Holdings (ZBH) | 0.2 | $23M | 212k | 109.23 | |
| Xencor (XNCR) | 0.2 | $23M | 1.0M | 21.97 | |
| Mirati Therapeutics | 0.2 | $21M | 681k | 31.47 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.2 | $20M | 115k | 176.07 | |
| Pieris Pharmaceuticals | 0.2 | $20M | 7.3M | 2.75 | |
| Connecture | 0.2 | $18M | 1.7M | 10.56 | |
| Teva Pharmaceutical Inds Adr (TEVA) | 0.2 | $18M | 307k | 59.10 | |
| Stryker Corporation (SYK) | 0.1 | $18M | 186k | 95.57 | |
| eHealth (EHTH) | 0.1 | $17M | 1.3M | 12.69 | |
| Merge Healthcare | 0.1 | $16M | 3.3M | 4.80 | |
| Advaxis Com New | 0.1 | $15M | 755k | 20.33 | |
| ImmunoGen | 0.1 | $15M | 1.0M | 14.38 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.1 | $14M | 115k | 123.48 | |
| Insulet Corporation (PODD) | 0.1 | $14M | 453k | 30.98 | |
| Sinovac Biotech SHS (SVA) | 0.1 | $14M | 2.7M | 5.25 | |
| Ensign (ENSG) | 0.1 | $13M | 248k | 51.06 | |
| Cellectis S A Sponsored Ads (CLLS) | 0.1 | $13M | 350k | 36.08 | |
| Aetna | 0.1 | $12M | 96k | 127.46 | |
| Cardinal Health (CAH) | 0.1 | $12M | 146k | 83.65 | |
| Macrogenics (MGNX) | 0.1 | $12M | 317k | 37.97 | |
| Sage Therapeutics (SAGE) | 0.1 | $11M | 150k | 73.00 | |
| Fluidigm Corp Del Note 2.750% 2/0 (Principal) | 0.1 | $10M | 12M | 0.87 | |
| Abbott Laboratories (ABT) | 0.1 | $10M | 211k | 49.08 | |
| Seres Therapeutics (MCRB) | 0.1 | $10M | 247k | 41.50 | |
| Spark Therapeutics | 0.1 | $10M | 167k | 60.27 | |
| Anacor Pharmaceuticals In | 0.1 | $10M | 129k | 77.43 | |
| Redhill Biopharma Sponsored Ads | 0.1 | $9.9M | 565k | 17.61 | |
| Lion Biotechnologies | 0.1 | $9.4M | 1.0M | 9.17 | |
| Incyte Corp Note 1.250%11/1 (Principal) | 0.1 | $8.7M | 4.3M | 2.05 | |
| Incyte Corp Note 0.375%11/1 (Principal) | 0.1 | $8.6M | 4.3M | 2.03 | |
| Roka Bioscience | 0.1 | $8.4M | 3.2M | 2.60 | |
| OraSure Technologies (OSUR) | 0.1 | $8.4M | 1.6M | 5.39 | |
| Alimera Sciences | 0.1 | $6.9M | 1.5M | 4.61 | |
| Invitae (NVTAQ) | 0.1 | $6.8M | 457k | 14.88 | |
| Pernix Therapeutics Holdings | 0.1 | $6.4M | 1.1M | 5.92 | |
| Biotie Therapies Oyj Sponsored Adr | 0.0 | $5.4M | 269k | 19.97 | |
| Orexigen Therapeutics Note 2.750%12/0 (Principal) | 0.0 | $4.9M | 5.2M | 0.94 | |
| Fate Therapeutics (FATE) | 0.0 | $4.5M | 693k | 6.47 | |
| Avalanche Biotechnologies In Call Option | 0.0 | $4.1M | 250k | 16.24 | |
| Biolinerx Sponsored Adr | 0.0 | $3.0M | 1.1M | 2.66 | |
| MannKind Corporation Put Option | 0.0 | $2.6M | 450k | 5.69 | |
| PDL BioPharma Call Option | 0.0 | $2.4M | 380k | 6.43 | |
| Ptc Therapeutics I Put Option (PTCT) | 0.0 | $2.4M | 50k | 48.14 | |
| Qlt | 0.0 | $2.1M | 500k | 4.13 | |
| Eleven Biotherapeutics | 0.0 | $2.1M | 732k | 2.82 | |
| Dicerna Pharmaceuticals | 0.0 | $2.0M | 142k | 13.95 | |
| Cempra | 0.0 | $1.7M | 50k | 34.36 | |
| Cogentix Medical | 0.0 | $1.6M | 991k | 1.62 | |
| Vital Therapies Put Option | 0.0 | $1.6M | 75k | 21.11 | |
| Amarin Corp Spons Adr New (AMRN) | 0.0 | $861k | 350k | 2.46 | |
| Biomarin Pharmaceutical Note 1.500%10/1 (Principal) | 0.0 | $792k | 500k | 1.58 | |
| Biomarin Pharmaceutical Note 0.750%10/1 (Principal) | 0.0 | $771k | 500k | 1.54 |
